Get Full Government Meeting Transcripts, Videos, & Alerts Forever!
Year-end benefits report: 2025 claims rise; specialty drugs drive costs, consultant says
Summary
Lynn Fontaine told the committee that 2025 group health claims rose roughly 7% year‑over‑year, with prescription drugs—especially high‑cost specialty medications—accounting for the largest share of plan costs and pushing medical trend above past averages.
Lynn Fontaine presented the committee with the district's 2025 year‑end group health claims, saying total claims rose about 7% from the prior year and that prescription drugs are now the largest single driver of costs. "Prescription drugs, I'll note, is 41.7% of our of our total claims," Fontaine said, highlighting that a small share of specialty medications accounts for a disproportionate share of spending.
Fontaine told board members the plan saw rebates and discounts that helped offset…
Already have an account? Log in
Subscribe to keep reading
Unlock the rest of this article — and every article on Citizen Portal.
- Unlimited articles
- AI-powered breakdowns of topics, speakers, decisions, and budgets
- Instant alerts when your location has a new meeting
- Follow topics and more locations
- 1,000 AI Insights / month, plus AI Chat
